Cronin M. Jane's most recent trade in Cleveland-Cliffs Inc was a trade of 4,926 Common Shares done at an average price of $8.1 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cleveland-Cliffs Inc | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 8.12 per share. | 01 Jul 2025 | 4,926 | 48,015 (0%) | 0% | 8.1 | 39,999 | Common Shares |
| Cleveland-Cliffs Inc | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 18,567 | 43,089 (0%) | 0% | 0 | Common Shares | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 1346.52 per share. | 26 Mar 2025 | 27 | 640 (0%) | 0% | 1346.5 | 36,356 | Common Stock |
| Cleveland-Cliffs Inc | Jane M. Cronin | Director | Purchase of securities on an exchange or from another person at price $ 10.56 per share. | 28 Feb 2025 | 10,000 | 24,522 (0%) | 0% | 10.6 | 105,606 | Common Shares |
| Cleveland-Cliffs Inc | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,522 | 14,522 (0%) | 0% | 0 | Common Shares | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Sale of securities on an exchange or to another person at price $ 398.06 per share. | 25 Nov 2024 | 5,161 | 16,816 (0%) | 0% | 398.1 | 2,054,388 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.85 per share. | 25 Nov 2024 | 3,700 | 21,977 (0%) | 0% | 136.9 | 506,345 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 3,700 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.10 per share. | 25 Nov 2024 | 1,461 | 18,277 (0%) | 0% | 140.1 | 204,686 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 1,461 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 543 | 16,360 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 295.83 per share. | 25 Nov 2024 | 338 | 17,154 (0%) | 0% | 295.8 | 99,991 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 338 | 2,562 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 397.93 per share. | 25 Nov 2024 | 251 | 16,903 (0%) | 0% | 397.9 | 99,880 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 450 | 450 | - | - | Stock Option | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 2,100 | 2,100 | - | - | Employee Stock Option (Right to Buy) | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 1367.78 per share. | 25 Sep 2024 | 27 | 613 (0%) | 0% | 1367.8 | 36,930 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Sale of securities on an exchange or to another person at price $ 350.75 per share. | 30 Jul 2024 | 9,320 | 16,816 (0%) | 0% | 350.8 | 3,268,990 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.98 per share. | 30 Jul 2024 | 7,320 | 24,136 (0%) | 0% | 128.0 | 936,814 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2024 | 7,320 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2024 | 2,000 | 3,700 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.85 per share. | 30 Jul 2024 | 2,000 | 26,136 (0%) | 0% | 136.9 | 273,700 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 1172.19 per share. | 22 Mar 2024 | 31 | 586 (0%) | 0% | 1172.2 | 36,338 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 186.85 per share. | 07 Mar 2024 | 535 | 16,958 (0%) | 0% | 186.9 | 99,965 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 535 | 4,565 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 440 | 3,160 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 227.05 per share. | 07 Mar 2024 | 440 | 17,398 (0%) | 0% | 227.1 | 99,902 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 342.94 per share. | 07 Mar 2024 | 291 | 16,816 (0%) | 0% | 342.9 | 99,796 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 343.49 per share. | 07 Mar 2024 | 291 | 17,107 (0%) | 0% | 343.5 | 99,956 | Common Stock |
| Sherwin-Williams | Cronin Jane M. | SVP - Enterprise Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 1,125 | 16,765 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Cronin M. Jane | SVP - Enterprise Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.98 per share. | 15 Feb 2024 | 342 | 16,423 (0%) | 0% | 313.0 | 107,039 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 670 | 670 | - | - | Stock Option | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 2,700 | 2,700 | - | - | Employee Stock Option (Right to Buy) | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 864.70 per share. | 25 Sep 2023 | 43 | 555 (0%) | 0% | 864.7 | 37,182 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 697.13 per share. | 27 Mar 2023 | 53 | 512 (0%) | 0% | 697.1 | 36,948 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 3,150 | 16,597 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 226.23 per share. | 17 Feb 2023 | 957 | 15,640 (0%) | 0% | 226.2 | 216,502 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 855 | 855 | - | - | Stock Option | |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2022 | 3,000 | 3,000 | - | - | Employee Stock Option (Right to Buy) | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 587.10 per share. | 23 Sep 2022 | 63 | 459 (0%) | 0% | 587.1 | 36,987 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Purchase of securities on an exchange or from another person at price $ 693.75 per share. | 26 Aug 2022 | 8 | 396 (0%) | 0% | 693.8 | 5,550 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.98 per share. | 24 Aug 2022 | 780 | 13,447 (0%) | 0% | 128.0 | 99,824 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Enterprise Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 780 | 1,920 | - | - | Employee Stock Option (Right to Buy) | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 646.03 per share. | 28 Mar 2022 | 58 | 388 (0%) | 0% | 646.0 | 37,470 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 3,751 | 13,837 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.65 per share. | 15 Feb 2022 | 1,170 | 12,667 (0%) | 0% | 272.7 | 319,001 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Purchase of securities on an exchange or from another person at price $ 634.27 per share. | 19 Nov 2021 | 300 | 330 (0%) | 0% | 634.3 | 190,281 | Common Stock |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2021 | 799 | 799 | - | - | Stock Option | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 2,900 | 2,900 | - | - | Employee Stock Option (Right to Buy) | |
| Transdigm Group | Jane M. Cronin | Director | Grant, award, or other acquisition of securities at price $ 612.97 per share. | 28 Sep 2021 | 30 | 30 (0%) | 0% | 613.0 | 18,389 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Sale of securities on an exchange or to another person at price $ 308.22 per share. | 16 Aug 2021 | 7,722 | 10,086 (0%) | 0% | 308.2 | 2,380,075 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 92.55 per share. | 16 Aug 2021 | 7,722 | 17,094 (0%) | 0% | 92.5 | 714,671 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 3,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 2,802 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1,920 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.10 per share. | 16 Aug 2021 | 714 | 17,808 (0%) | 0% | 140.1 | 100,031 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 713 | 10 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1 | 725 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Sale of securities on an exchange or to another person at price $ 700.00 per share. | 08 Mar 2021 | 1,895 | 3,124 (0%) | 0% | 700 | 1,326,500 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 227.73 per share. | 08 Mar 2021 | 669 | 4,433 (0%) | 0% | 227.7 | 152,351 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 239.55 per share. | 08 Mar 2021 | 586 | 5,019 (0%) | 0% | 239.5 | 140,376 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 360 | 640 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 277.65 per share. | 08 Mar 2021 | 360 | 3,915 (0%) | 0% | 277.7 | 99,954 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 340 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 340 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 329 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 246 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Sale of securities on an exchange or to another person at price $ 693.89 per share. | 08 Mar 2021 | 151 | 3,764 (0%) | 0% | 693.9 | 104,777 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 928 | 3,843 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 714.62 per share. | 16 Feb 2021 | 288 | 3,555 (0%) | 0% | 714.6 | 205,811 | Common Stock |
| Sherwin-Williams | Jane M. Cronin | SVP - Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2020 | 1,200 | 1,200 | - | - | Employee Stock Option (Right to Buy) |